Oncology OSD & Injectable Facility, Iraq
A greenfield oncology-focused pharmaceutical manufacturing facility engineered to support high-containment Oral Solid Dosage (OSD) and sterile injectable operations aligned with Ministry of Health (MOH) Iraq regulatory expectations. The project was envisioned as a future-ready pharmaceutical infrastructure integrating contamination-controlled manufacturing environments, sterile processing systems, and process-driven operational planning within a highly specialized oncology manufacturing framework.
Location
Iraq
Area
7,000 sqm
IN THIS PROJECT
Inotek was engaged for the complete conceptualisation, planning, and multidisciplinary engineering of the facility, developing the project from first principles through a regulatory-first and process-centric engineering approach.
The engineering strategy focused on high-containment zoning, sterile injectable infrastructure, contamination control philosophy, HVAC pressure cascade planning, utility engineering, and operational segregation suitable for oncology-oriented multi-product manufacturing operations.
Special emphasis was placed on integrating biosafety considerations, operator protection philosophy, sterile integrity, and manufacturing efficiency into a unified engineering framework aligned with MOH Iraq expectations and international pharmaceutical engineering practices.
METRICS / BRAND PHILOSOPHY SECTION
Regulatory-First Pharmaceutical Engineering
Pharmaceutical facilities handling oncology and sterile operations demand engineering strategies that go beyond conventional cleanroom execution.
At Inotek, facilities are developed around contamination behaviour, operational risk logic, containment philosophy, and regulatory predictability — ensuring that compliance integrity is embedded into the engineering framework from the earliest design stages.
High-Containment Engineering Integration
The project integrated oncology containment infrastructure, sterile manufacturing systems, cleanroom engineering, HVAC cascade strategy, utility coordination, and multidisciplinary engineering workflows within a unified operational environment.
Designed as a scalable pharmaceutical infrastructure platform, the facility incorporated containment-oriented engineering principles and operational zoning strategies aligned with long-term regulatory and manufacturing objectives.
“At Inotek, pharmaceutical engineering is not approached as isolated design disciplines. It is approached as an interconnected regulatory ecosystem where process flow, containment logic, cleanroom behaviour, utilities, and operational risk must function together predictably under real manufacturing conditions.”
Oncology OSD
